Alnylam Halts Patent Row Over Pfizer, BioNTech COVID-19 Vax
By Ryan Davis · May 14, 2025, 5:54 PM EDT
Alnylam Pharmaceuticals has decided to end a district court patent case over the COVID-19 vaccine made by Pfizer and BioNTech, asking a Delaware federal judge Tuesday to rule that the companies...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login